An open-label, randomised, parallel-group, multi-center study to evaluate the efficacy and safety of enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism in patients following acute ischemic stroke.

Trial Profile

An open-label, randomised, parallel-group, multi-center study to evaluate the efficacy and safety of enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism in patients following acute ischemic stroke.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Jan 2011

At a glance

  • Drugs Enoxaparin sodium; Heparin
  • Indications Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PREVAIL
  • Most Recent Events

    • 30 Nov 2009 Results reported in Stroke.
    • 11 Jul 2009 Results of an economic analysis of this trial were reported at 22nd Congress of the International Society on Thrombosis and Haemostasis.
    • 21 Apr 2007 Results reported in Lancet.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top